Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage I Bladder Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04601766
What this trial is testing

A Phase I, Two-phase, Crossover Study to Evaluate the Safety, Tolerability and Pharmacokinetics of APL-1501 ER Tablets

Who this might be right for
Bladder Cancer
Asieris Pharmaceuticals (AUS) Pty Ltd. 12
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT02844816
What this trial is testing

Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer

Who this might be right for
Recurrent Bladder Urothelial CarcinomaStage 0a Bladder Urothelial Carcinoma AJCC v6 and v7Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7+1 more
National Cancer Institute (NCI) 172
Early research (Phase 1)Study completedNCT04319757
What this trial is testing

ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors

Who this might be right for
Locally Advanced Solid TumorMetastatic CancerSolid Tumor+2 more
Acepodia Biotech, Inc. 12
Early research (Phase 1)WithdrawnNCT04972253
What this trial is testing

Phase I BLASST-3 Trial

Who this might be right for
Bladder Transitional Cell CarcinomaBladder CancerFibroblast Growth Factor Receptor
Guru P. Sonpavde
Large-scale testing (Phase 3)Study completedNCT00004154
What this trial is testing

Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder Cancer

Who this might be right for
Bladder Cancer
M.D. Anderson Cancer Center 111
Large-scale testing (Phase 3)Study completedNCT00445601
What this trial is testing

S0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer

Who this might be right for
Bladder Cancer
SWOG Cancer Research Network 406
Early research (Phase 1)Study completedNCT03258593
What this trial is testing

Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)

Who this might be right for
Urinary Bladder Neoplasms
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT00238420
What this trial is testing

Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer

Who this might be right for
Bladder Urothelial CarcinomaStage I Bladder Cancer AJCC v6 and v7Stage II Bladder Cancer AJCC v6 and v7+1 more
National Cancer Institute (NCI) 70
Post-approval studies (Phase 4)Study completedNCT02910596
What this trial is testing

Effectiveness of Bethanechol Chloride and Early Bladder Training for Prevention of Bladder Dysfunction After Radical Hysterectomy in Cervical Cancer Stage IB - IIA

Who this might be right for
Bladder Dysfunction
Department of Medical Services Ministry of Public Health of Thailand 56
Testing effectiveness (Phase 2)Active Not RecruitingNCT04644068
What this trial is testing

Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies

Who this might be right for
Ovarian CancerBreast CancerPancreatic Cancer+10 more
AstraZeneca 702
Large-scale testing (Phase 3)UnknownNCT00553345
What this trial is testing

Selenium and Vitamin E in Preventing Cancer Progression and Recurrence in Patients With Early-Stage Bladder Cancer

Who this might be right for
Bladder Cancer
University of Birmingham 515
Early research (Phase 1)Study completedNCT02311101
What this trial is testing

Phase I Mitomycin Combined With Bacillus Calmette-Guérin (BCG) for Bladder Cancer

Who this might be right for
Urinary Bladder Neoplasm
The University of Texas Health Science Center at San Antonio 18
Testing effectiveness (Phase 2)Study completedNCT04892342
What this trial is testing

Study of ESG401 in Adults With Solid Tumors

Who this might be right for
Neoplasms, BreastNeoplasms, LungNeoplasms,Colorectal+3 more
Shanghai Escugen Biotechnology Co., Ltd 156
Early research (Phase 1)Study completedNCT01517464
What this trial is testing

A Phase I Study of Systemic Gene Therapy With SGT-94 in Patients With Solid Tumors

Who this might be right for
Neoplasm
SynerGene Therapeutics, Inc. 13
Early research (Phase 1)Study completedNCT00413322
What this trial is testing

Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors

Who this might be right for
Tumor
Valerio Therapeutics 35
Early research (Phase 1)Study completedNCT00782587
What this trial is testing

Study of Immediate Post-Operative Intravesical Instillation of Chemophase® in Patients With Superficial Bladder Cancer

Who this might be right for
Superficial Bladder Cancer
Halozyme Therapeutics 14
Early research (Phase 1)Study completedNCT00544609
What this trial is testing

Sorafenib and Radiotherapy in the Treatment of Invasive Bladder Cancer With Conservative Intent

Who this might be right for
Bladder Cancer
Spanish Oncology Genito-Urinary Group 10
Testing effectiveness (Phase 2)Looking for participantsNCT05944237
What this trial is testing

HTL0039732 in Participants With Advanced Solid Tumours

Who this might be right for
NeoplasmsProstatic Neoplasms, Castration-ResistantStomach Neoplasms+11 more
Cancer Research UK 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT02202772
What this trial is testing

Intravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) in the Treatment Urothelial Carcinoma of the Bladder

Who this might be right for
Urothelial Carcinoma of the Urinary Bladder
Guarionex J. Decastro 51
Next Page